| Literature DB >> 33168576 |
Waradon Sungnak1, Allon Wagner2, Monika S Kowalczyk3, Lloyd Bod1, Yoon-Chul Kye1, Peter T Sage1,4, Arlene H Sharpe1,4, Raymond A Sobel5, Francisco J Quintana6, Orit Rozenblatt-Rosen3, Aviv Regev3, Chao Wang1, Nir Yosef2, Vijay K Kuchroo7,3,6.
Abstract
T follicular regulatory (TFR) cells limit Ab responses, but the underlying mechanisms remain largely unknown. In this study, we identify Fgl2 as a soluble TFR cell effector molecule through single-cell gene expression profiling. Highly expressed by TFR cells, Fgl2 directly binds to B cells, especially light-zone germinal center B cells, as well as to T follicular helper (TFH) cells, and directly regulates B cells and TFH in a context-dependent and type 2 Ab isotype-specific manner. In TFH cells, Fgl2 induces the expression of Prdm1 and a panel of checkpoint molecules, including PD1, TIM3, LAG3, and TIGIT, resulting in TFH cell dysfunction. Mice deficient in Fgl2 had dysregulated Ab responses at steady-state and upon immunization. In addition, loss of Fgl2 results in expansion of autoreactive B cells upon immunization. Consistent with this observation, aged Fgl2-/- mice spontaneously developed autoimmunity associated with elevated autoantibodies. Thus, Fgl2 is a TFR cell effector molecule that regulates humoral immunity and limits systemic autoimmunity.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33168576 PMCID: PMC7725915 DOI: 10.4049/jimmunol.2000748
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422